2.Current Status for Cord Blood Transplantation and Public Cord Blood Bank in Korea.
Sue SHIN ; Eun Youn ROH ; Jong Hyun YOON
Korean Journal of Blood Transfusion 2013;24(2):103-110
Cord blood is one of the promising sources of hematopoietic stem cell and the public cord blood bank should cryopreserve only high quality, conforming cord blood units for transplantation. Cryopreserved cord blood units have several advantages over other hematopoietic stem cell sources such as bone marrow or mobilized peripheral stem cells; cord blood is in the ready-to-use state after the necessary testing and cause less graft-versus-host disease due to cellular immaturity. The limiting factor is the restricted cell number, which resulted in delayed engraftment and immunologic reconstitution. Selection of cord blood for patients is determined by two criteria: the number of total nucleated cell and the matching of human leukocyte antigen. The cord blood inventory required for any given ethnicity is determined by HLA diversity. In terms of growing interest of cord blood as a stem cell source, we reviewed the current status of cord blood related issues in Korea.
Bone Marrow
;
Cell Count
;
Fetal Blood
;
Fibrinogen
;
Graft vs Host Disease
;
Hematopoietic Stem Cell Transplantation
;
Hematopoietic Stem Cells
;
Humans
;
Korea
;
Leukocytes
;
Stem Cells
;
Transplants
3.Dietary Very Long Chain Saturated Fatty Acids and Metabolic Factors: Findings from the Korea National Health and Nutrition Examination Survey 2013.
Youn Sue LEE ; Yoonsu CHO ; Min Jeong SHIN
Clinical Nutrition Research 2015;4(3):182-189
The present study was aim to evaluate the association between very long chain saturated fatty acids (VLSFAs) and metabolic syndrome (MetS) in Korean population. The study population were recruited from the Korea National Health and Nutrition Examination Survey VI (2013). Using the cross-sectional study design, socio-demographic factors, medical history, and clinical measurements were investigated according to quartiles of VLSFAs intake. The associations between each and sum of VLSFAs intake and MetS were assessed by logistic regression. The result indicated that higher intake of VLSFAs was significantly associated with favorable metabolic status, including lower levels of circulating triglyceride (TG) (p < 0.05). Additionally, subjects with higher intake of arachidic acid and total VLSFAs were negatively associated with MetS risk compared to subjects with lower intake of those fatty acids (p < 0.05). In conclusion, dietary VLSFAs intake was associated with metabolic risk factors and lower risk of MetS in Korean population.
Cross-Sectional Studies
;
Fatty Acids*
;
Korea*
;
Logistic Models
;
Nutrition Surveys*
;
Risk Factors
;
Triglycerides
4.Association of Leukotriene C4 Synthase Gene Polymorphism with Clinical Response to Montelukast in Childhood Asthma.
Korean Journal of Pediatrics 2005;48(7):766-771
PURPOSE: Cysteinyl leukotrienes are important inflammatory mediators in the pathogenesis of asthma; therefore interruption of cysteinyl leukotrienes by leukotriene receptor antagonists improves clinical symptoms in the management of patients with mild to moderate asthma. We evaluated whether clinical response to montelukast, a leukotriene receptor antagonist, in childhood asthma was predicted by genotypes of leukotriene C4 synthase (LTC4S) promoter gene polymorphism. METHODS: An 8-week prospective, open trial of montelukast was carried out in 161 children with mild to moderate asthma. Genotyping of LTC4S gene polymorphism was determined by restriction fragment length polymorphism. RESULTS: The distribution of the LTC4S genotypes AA, AC, and CC was 70.8 percent, 23.6 percent, and 5.6 percent, respectively in asthma group and 74.0 percent, 22.6 percent, and 3.4 percent, respectively in control group. A statistically significant difference in the distribution of LTC4S genotype was not observed between the asthma and the control groups, and there was no significant difference between the LTC4S genotype and asthma severity. The responders to montelukast were significantly prevalent in the mild asthma group (P< 0.05). There was no significant difference in the distribution of the responders compared to non-responders within genotype in the total asthma group or the moderate asthma group. However, the responsiveness for montelukast was significant difference within genotype for both AA and AC/CC in the mild asthma group: The AA genotype was more included in the responder group (P< 0.05). CONCLUSION: In the mild persistent asthma group, the A allele of LTC4S polymorphism may be regarded as a predictable factor for clinical response to montelukast. However, LTC4S polymorphism was not significantly associated with the clinical response to montelukast in asthmatic children.
Alleles
;
Asthma*
;
Child
;
Genotype
;
Humans
;
Leukotriene Antagonists
;
Leukotriene C4*
;
Leukotrienes
;
Polymorphism, Restriction Fragment Length
;
Prospective Studies
;
Receptors, Leukotriene
5.Polymorphism of Matrix Metalloproteinase-3 Promoter Gene as a Risk Factor for Coronary Artery Lesions in Kawasaki Disease.
Jeong Ah PARK ; Kyung Sue SHIN ; Youn Woo KIM
Journal of Korean Medical Science 2005;20(4):607-611
Kawasaki disease (KD) is a major cause of acquired coronary artery diseases in childhood. The serum levels of matrix metalloproteinase (MMP)-3 and MMP-9 in KD have been reported to be significantly higher than other diseases. Several studies have demonstrated that MMP-3 5A/6A polymorphism and MMP-9 C-1562T polymorphism modify each transcriptional activity in allele specific manner. We hypothesized that these polymorphisms may play a role as a risk factor for development of coronary artery lesions (CAL) in KD. Eighty-three patients, diagnosed with KD in Cheju National University Hospital from January 2000 to February 2004, were divided into two groups according to the presence of CAL. Genotyping of MMP-3 and MMP-9 gene polymorphisms were determined by restriction fragment length polymorphism. With regard to MMP-3 gene polymorphism, the KD with CAL group had a higher frequency of 6A/6A genotype than control group (p=0.0127) and the KD without CAL group (p=0.0036). However, no significant differences in the allele and genotype distributions of the MMP-9 polymorphism were observed. These findings suggest that MMP-3 6A/6A genotype may be an independent risk factor for CAL formation in KD.
Adolescent
;
Adult
;
Aged
;
Alleles
;
Child
;
Child, Preschool
;
Coronary Arteriosclerosis/enzymology/etiology/*genetics
;
Female
;
Gelatinase B/genetics
;
Gene Frequency
;
Genotype
;
Humans
;
Infant
;
Male
;
Middle Aged
;
Mucocutaneous Lymph Node Syndrome/*complications
;
*Polymorphism, Genetic
;
Promoter Regions (Genetics)/*genetics
;
Research Support, Non-U.S. Gov't
;
Risk Factors
;
Stromelysin 1/*genetics
6.Expression of Co-stimulatory Molecules and STAT/SOCS Signaling Factors in the Splenocytes of Mice Tolerized against Arthritis by Oral Administration of Type II Collagen.
Kang Eun LEE ; Sue Yun HWANG ; So Youn MIN ; Ho Youn KIM
Immune Network 2003;3(3):248-254
Oral administration of antigen has long been used in the induction of immune tolerance in various animal models of autoimmune diseases including rheumatoid arthritis (RA). Alleveation of arthritogenic symptoms has been reported from RA patients who received oral administration of type II collagen (CII) without side effects, however its rather inconsistent therapeutic efficacy and variation among patients calls for more detailed investigation on the mechanism of oral tolerance to be settled as regular treatment for RA. In an attempt to understand the immunogenic processes underpinning tolerance induction by orally administered CII, we analyzed changes in the expression of costimulatory molecules and STAT/SOCS signaling messengers in the mouse model of collagen induced arthritis (CIA). We found thatin the spleen of CIA mice, that has been undergone repeated oral feeding of CII prior to the induction of arthritis, showed increased promortion of CTLA4 expressing lymphocytes than in the spleen of PBS fed control. On the other hand, cells expressing CD28 or ICOS were decreased in the spleen of tolerized mice. Tolerance induction by oral CII administration also enhanced the expression of STAT6 in both RNA and protein level, while not affecting the expression of STAT3. The expression of SOCS3, which hasbeen known to transmit STAT-mediated signals from Th2 type cytokines, remained unchanged in the spleen of tolerized mice. Interestingly transcript of SOCS1, which has been associated with Th1 related pathways, was only visible in the spleen of tolerized but not of control mice, suggesting that as in the case of IL-6 signaling, it may exert a feed back inhibition toward the Th1 type stimulation.
Administration, Oral*
;
Animals
;
Arthritis*
;
Arthritis, Rheumatoid
;
Autoimmune Diseases
;
Collagen
;
Collagen Type II*
;
Cytokines
;
Hand
;
Humans
;
Immune Tolerance
;
Interleukin-6
;
Lymphocytes
;
Mice*
;
Models, Animal
;
RNA
;
Spleen
7.Generation and maintenance of type II collagen-specific T-cell line expressing conserved TCR-CDR3 motifs among patients with rheumatoid arthritis Author.
Seung Hoon KIM ; Mi La CHO ; Jee Hee YOUN ; Sung Hwan PARK ; Sue Yun HWANG ; Ho Youn KIM ; Chul Soo CHO
Immune Network 2001;1(1):61-69
BACKGROUND: To determine the molecular structure of type II collagen-specific T-cell receptors associated with rheumatoid arthritis (RA). METHODS: We generated CII-specific T-cell lines of 8 RA patient s by prolonged in vitro culture with bovine CII (bCII) and the immunogenic peptide (256-270) of human CII. The proliferation response towards CII stimulation was measured from the uptake of 3 H-thymidine. Changes in the secretion of Th 1 and Th2 cytokines in the culture supernatent were measured by ELISA. The TCR clonotypes of these T-cells were examined by RT-PCR/ SSCP analyses of all 22 V beta chains. RESULTS: T-cells from patients' tissue exhibited strong proliferation index upon CII stimulation, which was maintained up to 6 months in the culture. The secretion of INF-gamma from these T-cells increased along with the duration of culture time, while the amount of IL-4 production did not show significant changes. The SSCP band patterns of patients' T-cells appear as discrete bands unlike the smeary streak produced from normal samples. Some SSCP bands, each representing selected expansion of a TCR containing certain subtype of V beta peptides, appeared to be identical in more than one patients. Among these, the expansion of SSCP band representing the V beta 14 CDR3 region persisted after switching the antigen to the immunogenic human peptide (256-270). CONCLUSION: CII-reactive T-cells expressing distinct CDR3 motifs are selectively expanded in the peripheral blood and synovial fluid of RA patients, and their persistent proliferation upon CII stimulation, as well as the production Th 1-type cytokines, may play pivotal roles in RA pathogenesis.
Arthritis, Rheumatoid*
;
Cytokines
;
Enzyme-Linked Immunosorbent Assay
;
Humans
;
Interleukin-4
;
Molecular Structure
;
Peptides
;
Polymorphism, Single-Stranded Conformational
;
Receptors, Antigen, T-Cell
;
Synovial Fluid
;
T-Lymphocytes*
8.Iron Deficiency and Hemoglobin Content of RBC in Infants.
Sue SHIN ; Ju Young CHANG ; Jong Seung KIM ; Eun Youn ROH ; Jong Hyun YOON
The Korean Journal of Laboratory Medicine 2005;25(1):14-19
BACKGROUND: Iron deficiency is one of the commonest nutritional diseases in young children, which influences cognitive performance and motor development. For the diagnosis of iron deficiency in infants, we evaluated several parameters obtained during the test of routine complete blood count. METHODS: A total of 192 full-term infants were studied. They were aged from 6 to 12 months, who visited Boramae Hospital from Aug 2002 to Oct 2004 according to their routine check up schedules. Venous blood was drawn to determine hemoglobin, mean corpuscular volume, mean corpuscular hemoglobin, hemoglobin content (CH), hemoglobin content of reticulocyte and red cell distribution width (RDW) using ADVIA 120 (Bayer Diagnostics, NY, USA). For iron status, iron, total iron binding capacity and ferritin were determined. The normal, iron deficiency, and iron deficiency anemia groups were defined on the basis of Hb level of 11 g/dL, transferrin saturation of 20%, and/or ferritin level of 12 microgram/L. RESULTS: The significant predictors of iron deficiency state were CH (P<0.001) and RDW (P=0.035). Infants with CH < or = 26 pg could be diagnosed as having an iron deficiency state with 80% sensitivity and 86% specificity. CONCLUSIONS: CH can be used as a new parameter to diagnose an iron deficiency state in infants with the advantage of cost saving and avoiding additional blood sampling. However the reference range should be established before clinical testings and the parameter should be generalized to other automatic analyzers.
Anemia, Iron-Deficiency
;
Appointments and Schedules
;
Blood Cell Count
;
Child
;
Cost Savings
;
Diagnosis
;
Erythrocyte Indices
;
Ferritins
;
Humans
;
Infant*
;
Iron*
;
Reference Values
;
Reticulocytes
;
Sensitivity and Specificity
;
Transferrin
9.Allele and Haplotype Frequencies of Human Leukocyte Antigen-A, -B, -C, -DRB1, and -DQB1 From Sequence-Based DNA Typing Data in Koreans.
Ji Won IN ; Eun Youn ROH ; Sohee OH ; Sue SHIN ; Kyoung Un PARK ; Eun Young SONG
Annals of Laboratory Medicine 2015;35(4):429-435
BACKGROUND: Data on allele frequencies (AFs) and haplotype frequencies (HFs) of HLA-C and -DQB1 are limited in Koreans. We investigated AFs and HFs of HLA-A, -B, -C, -DRB1, and -DQB1 in Koreans by high-resolution sequence-based typing (SBT). METHODS: Hematopoietic stem cells were obtained from 613 healthy, unrelated donors to analyze HLA-A, -B, -C, -DRB1, and -DQB1 genotypes by using AlleleSEQR HLA-A, -B, -C, -DRB1, and -DQB1 SBT kits (Abbott Molecular, USA), respectively. Alleles belonging to HLA-C*07:01/07:06 group were further discriminated by using PCR-sequence specific primer analysis. AFs and HFs were calculated by direct counting and maximum likelihood method, respectively. RESULTS: In all, 24 HLA-A, 46 HLA-B, 24 HLA-C, 29 HLA-DRB1, and 15 HLA-DQB1 alleles were identified. AFs and HFs of HLA-A, -B, and -DRB1 were similar to those reported previously. For the HLA-C locus, C*01:02 was the most common allele, followed by C*03:03, C*03:04, C*14:02, C*03:02, and C*07:02 (AF > or =7%). AFs of C*07:01 and C*07:06 were 0.16% and 3.18%, respectively. For the HLA-DQB1 locus, DQB1*03:01 was the most common allele, followed by DQB1*03:03, *03:02, *06:01, *05:01, *04:01, and *06:02 (AF > or =7%). AFs of DQB1*02:01 and DQB1*02:02 were 2.12% and 6.69%, respectively. HFs of A*33:03-C*07:06 and C*07:06-B*44:03 were 3.09% and 3.10%, respectively, while those of DRB1*07:01-DQB1*02:02 and DRB1*03:01-DQB1*02:01 were 6.61% and 2.04%, respectively. CONCLUSIONS: This study reported AFs and HFs of HLA, including HLA-C and -DQB1, in Koreans by using high-resolution SBT. These data can be used to resolve ambiguous results of HLA typing for organ and hematopoietic stem cell transplantations.
Alleles*
;
DNA Fingerprinting*
;
Gene Frequency
;
Genotype
;
Haplotypes*
;
Hematopoietic Stem Cells
;
Histocompatibility Testing
;
HLA Antigens
;
HLA-A Antigens
;
HLA-B Antigens
;
HLA-C Antigens
;
HLA-DRB1 Chains
;
Humans
;
Korea
;
Leukocytes*
;
Sequence Analysis
;
Unrelated Donors
10.A Case Report of a Poor Metabolizer of CYP2D6 Presented with Unusual Responses to Nortriptyline Medication.
Soo Youn LEE ; Chang Seok KI ; Kyung Sue HONG ; Jong Won KIM
Journal of Korean Medical Science 2004;19(5):750-752
We present a case with decreased metabolic activity of CYP2D6, a cytochrome P450 enzyme catalyzing the metabolism of nortriptyline (NT). Conventional dosage regimen led to toxic plasma concentration of NT and adverse effects such as dry mouth, constipation, and dizziness in this case with genotype CYP2D6*5/*10B. This case suggests the clinical usefulness of pharmacogenetic testing in individualized dosage adjustments of NT.
Antidepressive Agents, Tricyclic/*adverse effects/pharmacokinetics
;
Cytochrome P-450 CYP2D6/*genetics/metabolism
;
Depression/*drug therapy/genetics
;
Genotype
;
Humans
;
Male
;
Middle Aged
;
Nortriptyline/*adverse effects/pharmacokinetics